Cargando…

Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most important health problems in China. OBJECTIVES: This study analyzed expression of high-mobility group protein B1 (HMGB1) and inhibitor of apoptosis protein-2 (c-IAP2) proteins in HCC compared to paired para-tumor tissue samples to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Man Ru, Zhu, Li Ying, Yan, Bing Zhu, Chen, Li Yan, Wang, Fu Xiang, Ma, Ying Ji, Yang, Bao Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310020/ https://www.ncbi.nlm.nih.gov/pubmed/25685165 http://dx.doi.org/10.5812/hepatmon.23552

Ejemplares similares

HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis
por: Lu, Kai, et al.
Publicado: (2023)

MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma
por: Yan, Jianing, et al.
Publicado: (2018)

YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021)

The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
por: Wang, Xuanbin, et al.
Publicado: (2015)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma
por: Xiang, Yan, et al.
Publicado: (2016)

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
por: Augello, Claudia, et al.
Publicado: (2009)

Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1
por: Sun, Yuan-dong, et al.
Publicado: (2021)

Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein
por: Wang, Long-kun, et al.
Publicado: (2018)

HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2
por: Feng, Weibo, et al.
Publicado: (2023)

Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
por: Zhu, Wei, et al.
Publicado: (2021)

Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma
por: Yang, Xuejie, et al.
Publicado: (2023)

VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
por: Pu, Zhangya, et al.
Publicado: (2022)

TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression
por: Li, Lei, et al.
Publicado: (2021)

Antitumor Effect of Periplocin in TRAIL-Resistant Human Hepatocellular Carcinoma Cells through Downregulation of IAPs
por: Cheng, Chieh-Fang, et al.
Publicado: (2013)

Increased HMGB1 expression correlates with higher expression of c-IAP2 and pERK in colorectal cancer
por: Zhang, Wenjia, et al.
Publicado: (2019)

Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells
por: Zhen, Mao-Chuan, et al.
Publicado: (2016)

The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines
por: Chen, Ruo-Chan, et al.
Publicado: (2014)

Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p
por: Chen, Feiyu, et al.
Publicado: (2020)

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene
por: Niu, Zheyu, et al.
Publicado: (2022)

Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression
por: Zhang, Shouhua, et al.
Publicado: (2021)

The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)

Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury
por: Zhao, Guangyuan, et al.
Publicado: (2017)

LncSHRG promotes hepatocellular carcinoma progression by activating HES6
por: Xu, Ying-Chen, et al.
Publicado: (2017)

IAP Workshop
Publicado: (1996)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression
por: Gao, Xinyi, et al.
Publicado: (2023)

TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
por: Yang, Xu, et al.
Publicado: (2022)

SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway
por: Ding, Jun, et al.
Publicado: (2020)

Krüppel-like factor 5 promotes the progression of oral squamous cell carcinoma via the baculoviral IAP repeat containing 5 gene
por: Li, Yuehua, et al.
Publicado: (2022)

CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
por: Zou, Qiong, et al.
Publicado: (2023)

Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma
por: You, Bo, et al.
Publicado: (2015)

ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21
por: Xiang, Yuqi, et al.
Publicado: (2020)

Interferon-Induced Transmembrane Protein 3 Expression Upregulation Is Involved in Progression of Hepatocellular Carcinoma
por: Hou, Yuli, et al.
Publicado: (2021)

Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
por: McCabe, K E, et al.
Publicado: (2014)

Effects of Physiological and Synthetic IAP Antagonism on c-IAP-Dependent Signaling
por: Kocab, Andrew J., et al.
Publicado: (2015)

TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals
por: Liang, Lili, et al.
Publicado: (2020)

HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model
por: Li, Wen-Juan, et al.
Publicado: (2022)

Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression
por: Paschall, Amy V, et al.
Publicado: (2014)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
por: Zhou, Lisha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8btc4rg29v6to7oqq1dtnrscvs